Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-specific factors associated with tumour motion in lung stereotactic body radiation therapy from real-time tumour tracking traces.

Physics and imaging in radiation oncology·2026
Same author

A comprehensive investigation of the radiation isocentre spatial variability in linear accelerators: implications for commissioning, QA, and clinical protocols.

Physical and engineering sciences in medicine·2025
Same author

The lncRNA ELDR suppresses tumorigenicity of AML by interfering with DNA replication and chromatin accessibility.

Blood advances·2025
Same author

Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines.

Leukemia·2024
Same author

CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.

Blood advances·2023
Same author

Defining the elusive oncogenic role of the methyltransferase TMT1B.

Frontiers in oncology·2023
Same journal

Individualized Longitudinal ctDNA Monitoring in Melanoma Using Multiplexed USE-PCR.

Molecular diagnosis & therapy·2026
Same journal

Advances in Gene and Cellular Therapy in Friedreich Ataxia.

Molecular diagnosis & therapy·2026
Same journal

Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer.

Molecular diagnosis & therapy·2026
Same journal

Tividenofusp Alfa: First Approval.

Molecular diagnosis & therapy·2026
Same journal

Genetics of Cerebrotendinous Xanthomatosis.

Molecular diagnosis & therapy·2026
Same journal

Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy.

Molecular diagnosis & therapy·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.7K

Mining Cancer Transcriptomes: Bioinformatic Tools and the Remaining Challenges.

Thomas Milan1, Brian T Wilhelm2,3

  • 1Laboratory for High Throughput Biology, Institute for Research in Immunology and Cancer, Université de Montréal, Station Centre-Ville, P.O. Box 6128, Montreal, QC, H3C 3J7, Canada.

Molecular Diagnosis & Therapy
|February 24, 2017
PubMed
Summary
This summary is machine-generated.

Next-generation sequencing generates vast cancer genomics data. Improved bioinformatic tools are needed for easier access and analysis of RNA-sequencing data, ensuring data sharing and patient privacy.

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.1K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K

Related Experiment Videos

Last Updated: Mar 7, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.7K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.1K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Research

Background:

  • Next-generation sequencing (NGS) has revolutionized cancer genomics, producing large datasets from tumor samples.
  • Current efforts focus on improving specific algorithms for faster and more precise data analysis.
  • However, data accessibility for researchers lacking resources and expertise remains a significant challenge.

Purpose of the Study:

  • To review available bioinformatic tools for RNA-sequencing (RNA-seq) analysis in cancer genomics.
  • To highlight the need for more intuitive tools to improve access to public cancer genomics data.
  • To discuss critical issues of data sharing and patient privacy in cancer research.

Main Methods:

  • Focus on RNA-sequencing (RNA-seq) analysis within the cancer genomics domain.
  • Discussion of existing bioinformatic tools for exploring large-scale cancer data.
  • Exploration of challenges and solutions related to data accessibility and sharing.

Main Results:

  • Significant advancements in cancer genomics driven by NGS technologies.
  • Existing bioinformatic tools require adaptation or development for efficient data analysis.
  • A gap exists in the accessibility of generated data for the broader research community.

Conclusions:

  • Enhanced bioinformatic tools are crucial for maximizing the value of cancer genomics data.
  • Developing intuitive platforms is essential for democratizing access to public cancer data.
  • Addressing data sharing and patient privacy concerns is paramount for advancing cancer research.